- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$170.4b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$107.00
7D
3.4%
1Y
-11.6%
Bora Pharmaceuticals
Market Cap: NT$50.5b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$392.50
7D
3.7%
1Y
-44.3%
Lotus Pharmaceutical
Market Cap: NT$49.1b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$185.50
7D
5.1%
1Y
-17.4%
Oneness Biotech
Market Cap: NT$21.8b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$47.65
7D
9.2%
1Y
-30.8%
TaiMed Biologics
Market Cap: NT$15.5b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$57.70
7D
-0.5%
1Y
-31.5%
Medigen Vaccine Biologics
Market Cap: NT$15.4b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$47.45
7D
2.0%
1Y
9.3%
EirGenix
Market Cap: NT$14.0b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$47.40
7D
3.2%
1Y
-26.2%
Foresee Pharmaceuticals
Market Cap: NT$12.5b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.00
7D
-2.1%
1Y
-0.9%